Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Amesite Inc.AMST · Entity 8151 | Director | September 30, 2024 | October 02, 2024 |
| Amesite Inc.NONE · Entity 149985 | Director | April 27, 2018 | May 01, 2018 |
| Blue Laser Fusion, Inc.NONE · Entity 107871 | Director · General Counsel and Secretary | September 04, 2026 | September 09, 2026 |
| Palomino Laboratories Inc.PALX · Entity 9910 | Director · Secretary | July 31, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Amesite Inc.
Report date September 30, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 46,032 |
Reported balance
After 2024-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-09-30 · Grant · Acquired 4,898 · Balance 46,032 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share. F2: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMST common stock and/or the cash equivalent of such share.
F2: The reported securities were issued as "deferred stock units" in lieu of cash compensation earned for services as a director, and the number of deferred stock units received was calculated based on the closing share price on the last day of the quarter. The deferred stock units or cash equivalent will be issued to the reporting person upon completion of service as a member of the board of directors or, if earlier, a change in control.
Amesite Inc.
Report date April 27, 2018 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 41,667 |
Reported balance
After 2018-04-27 transaction · row 1
1 source rowRow 1 · 2018-04-27 · Purchase · Acquired 41,667 · Balance 41,667 |
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee footnote | 66,667 |
Reported balance
After 2018-04-27 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-04-27 · Purchase · Acquired 25,000 · Balance 66,667 F1: Includes 25,000 shares of common stock held of record by OGAWA Professional Corporation. The reporting person is the beneficial owner of OGAWA Professional Corporation and has voting and investment power over the securities held by OGAWA Professional Corporation. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 25,000 shares of common stock held of record by OGAWA Professional Corporation. The reporting person is the beneficial owner of OGAWA Professional Corporation and has voting and investment power over the securities held by OGAWA Professional Corporation.
Blue Laser Fusion, Inc.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 575,508 |
Ending reported balance
After 2026-09-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-04 · Grant · Acquired 568,235 · Balance 568,235 F1: Received in exchange for 900,000 shares of common stock (including 150,000 restricted shares of common stock) of Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF") in connection with the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Pre-Merger BLF (the "Merger") pursuant to the Agreement and Plan of Merger, dated September 4, 2026. Row 2 · 2026-09-04 · Other · Acquired 7,273 · Balance 575,508 F2: Pursuant to a subscription agreement, simultaneously with the closing of the Merger, the Reporting Person purchased 7,273 shares of common stock of the issuer in a private placement offering at a price per share of $27.50. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in exchange for 900,000 shares of common stock (including 150,000 restricted shares of common stock) of Blue Laser Subsidiary Inc. (f/k/a Blue Laser Fusion Inc., "Pre-Merger BLF") in connection with the merger of Blue Laser Fusion Acquisition Co., a subsidiary of the issuer, with and into Pre-Merger BLF (the "Merger") pursuant to the Agreement and Plan of Merger, dated September 4, 2026.
F2: Pursuant to a subscription agreement, simultaneously with the closing of the Merger, the Reporting Person purchased 7,273 shares of common stock of the issuer in a private placement offering at a price per share of $27.50.
Palomino Laboratories Inc.
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,882,500 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Other · Acquired 120,000 · Balance 1,882,500 F1: Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the "Purchaser"), Vega Links, Inc. ("VLI") and the stockholders as listed on Schedule A attached thereto (the "Stockholders"), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the "Shares"), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser ("Purchaser Stock"). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the "Purchaser"), Vega Links, Inc. ("VLI") and the stockholders as listed on Schedule A attached thereto (the "Stockholders"), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the "Shares"), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser ("Purchaser Stock"). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INPHI Corp
Report date April 20, 2021 · Filed April 20, 2021
Section 16 reporting ended · disclosed 2021-04-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 98,448 |
Reported balance
After 2021-04-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-04-20 · Grant · Acquired 20,456 · Balance 98,448 F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement") by and among by and among Marvell Technology Group Ltd., a Bermuda exempted company ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a Delaware corporation and a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation, a Delaware corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"), F2: (continued from footnote 1) and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). At the effective time of the Mergers, the restricted stock units that vest based on the per share market value of the shares of Inphi Common Stock (the "Inphi Common Stock") exceeding certain relative performance target levels (a "MVSU") were vested in full on April 20, 2020. The holder of such vested MVSUs became entitled to receive (subject to applicable withholding or other taxes) (i) an amount in cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU, and (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU. |
| Common StockSEC Table I · non-derivative | Direct | 42,218 |
Reported balance
After 2021-04-20 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-04-20 · Disposition to issuer · Disposed 56,230 · Balance 42,218 F3: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2021-04-20 · Disposition to issuer · Disposed 42,218 · Balance 0 F4: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 20, 2021, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 29, 2020 (the "Merger Agreement") by and among by and among Marvell Technology Group Ltd., a Bermuda exempted company ("Marvell"), Marvell Technology, Inc. (f/k/a Maui HoldCo, Inc.), a Delaware corporation and a wholly owned subsidiary of Marvell ("HoldCo"), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly owned subsidiary of HoldCo ("Bermuda Merger Sub"), Indigo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of HoldCo ("Delaware Merger Sub"), and Inphi Corporation, a Delaware corporation ("Inphi"), Bermuda Merger Sub merged with and into Marvell with Marvell as the surviving corporation and a wholly owned subsidiary of Holdco (the "Bermuda Merger"),
F2: (continued from footnote 1) and Delaware Merger Sub merged with and into Inphi with Inphi as the surviving corporation and a wholly owned subsidiary of Holdco (the "Delaware Merger" and, together with the Bermuda Merger, the "Mergers"). At the effective time of the Mergers, the restricted stock units that vest based on the per share market value of the shares of Inphi Common Stock (the "Inphi Common Stock") exceeding certain relative performance target levels (a "MVSU") were vested in full on April 20, 2020. The holder of such vested MVSUs became entitled to receive (subject to applicable withholding or other taxes) (i) an amount in cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU, and (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such vested MVSU.
F3: Disposed pursuant to the Merger Agreement, whereby at the effective time of the Mergers, the outstanding Inphi Common Stock was automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.00 in cash, without interest (in addition to cash in lieu of fractional shares).
F4: Per the terms of the Merger Agreement, (a) 35,025RSUs that were outstanding and vested immediately prior to the effective time of the Mergers (including 26,397 RSUs that only vest subject to delivery of an effective release) were cancelled in exchange for (subject to applicable withholding or other taxes), (i) an amount of cash equal to the product of (A) $66.00, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, (ii) a number of shares of HoldCo Common Stock equal to the product of (A) 2.323, multiplied by (B) the total number of shares of Inphi Common Stock subject to such RSU, and (b) 7,307 RSUs were forfeited.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2017 Filed Jul 5, 2017 18:35 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 131 | $34.30 | $4,493.30 |
DisclosureSEC source: 0001437749-17-012259 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 17:31 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 1,312 | $46.38 | $60,850.56 |
DisclosureSEC source: 0001437749-17-007347 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,811 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 20:14 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 1,434 | $44.12 | $63,268.08 |
DisclosureSEC source: 0001437749-17-007090 · rdgdoc.xml · nonDerivative · entry 3 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,123 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:14 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 2,220 | $44.16 | $98,035.20 |
DisclosureSEC source: 0001437749-17-007090 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,557 Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 19:13 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 16,000 | $42.99 | $687,840.00 |
DisclosureSEC source: 0001437749-17-006901 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,561 F2 · shares: The restricted stock units vest as to 25% of the shares on each of 4/19/2018, 4/19/2019, 4/19/2020, and 4/19/2021. Read SEC document |
| April 18, 2017 Filed Apr 20, 2017 19:13 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 4,303 | $44.12 | $189,848.36 |
DisclosureSEC source: 0001437749-17-006901 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,561 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 17:00 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 3,131 | $44.94 | $140,707.14 |
DisclosureSEC source: 0001437749-17-006740 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,864 Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 17:00 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 3,131 | $44.94 | $140,707.14 |
DisclosureSEC source: 0001437749-17-006739 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,864 Read SEC document |
| April 15, 2017 Filed Apr 18, 2017 17:00 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 1,566 | $44.46 | $69,624.36 |
DisclosureSEC source: 0001437749-17-006740 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,995 Read SEC document |
| April 15, 2017 Filed Apr 18, 2017 17:00 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 1,566 | $44.46 | $69,624.36 |
DisclosureSEC source: 0001437749-17-006739 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,995 Read SEC document |
| April 15, 2017 Filed Apr 24, 2017 20:14 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 784 | $44.46 | $34,856.64 |
DisclosureSEC source: 0001437749-17-007090 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,777 Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 16:14 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 119 | $45.63 | $5,429.97 |
DisclosureSEC source: 0001437749-17-006359 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,561 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 19:06 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 131 | $48.82 | $6,395.42 |
DisclosureSEC source: 0001437749-17-005956 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,680 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 11:14 UTC | INPHI Corp IPHI · Entity 140160 | Exercise / conversionEmployee Stock Option - right to buy · Derivative | 50,000 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001437749-17-003741 · rdgdoc.xml · derivative · entry 5 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2020-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option vests as to 25% of the shares on 1/2/14 and remaining shares vest in 36 monthly installments thereafter from 1/2/14 to 1/2/17. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 11:14 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 2,500 | $47.74 | $119,342.25 |
DisclosureSEC source: 0001437749-17-003741 · rdgdoc.xml · nonDerivative · entry 4 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,811 F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $47.615 to $47.82. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 11:14 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 8,800 | $46.90 | $412,718.24 |
DisclosureSEC source: 0001437749-17-003741 · rdgdoc.xml · nonDerivative · entry 3 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,311 F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $46.60 to $47.41. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 11:14 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 38,700 | $46.23 | $1,789,070.04 |
DisclosureSEC source: 0001437749-17-003741 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,111 F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $45.60 to $46.595. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 11:14 UTC | INPHI Corp IPHI · Entity 140160 | Exercise / conversionCommon Stock | 50,000 | $8.93 | $446,500.00 |
DisclosureSEC source: 0001437749-17-003741 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The exercise of options reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 17:03 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 836 | $50.90 | $42,552.40 |
DisclosureSEC source: 0001437749-17-003355 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,811 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 5 shares acquired on 2/9/2015 through the Company's qualified ESPP program. Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 21:40 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-003011 · rdgdoc.xml · nonDerivative · entry 3 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,642 F2 · shares: Represents a stock unit award approved in April 2016 subject to satisfaction of certain performance-vesting criteria that were achieved and certified, which award provides for 25% of the shares to vest on each of April 20, 2017, April 20, 2018, April 20, 2019, and April 20, 2020. Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 21:40 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 914 | $50.61 | $46,257.54 |
DisclosureSEC source: 0001437749-17-003011 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,642 Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 21:40 UTC | INPHI Corp IPHI · Entity 140160 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-003011 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,556 F1 · shares: Represents a stock unit award approved in September 2015 subject to satisfaction of certain performance-vesting criteria that were achieved and certified, which award provides for 43.75% of the shares to vest by the certification date and 6.25% of the shares to vest on the last day of each calendar quarter from March 31, 2017 through March 31, 2019. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 16:05 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 300 | $49.14 | $14,742.99 |
DisclosureSEC source: 0001437749-17-002680 · rdgdoc.xml · nonDerivative · entry 2 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,556 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $49.13 to $49.15. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 16:05 UTC | INPHI Corp IPHI · Entity 140160 | SaleCommon Stock | 15,876 | $48.88 | $776,050.63 |
DisclosureSEC source: 0001437749-17-002680 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,856 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sales price for a number of transactions effected at prices ranging from $48.12 to $49.11. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 591 shares acquired on 02/09/2017 through the Company's qualified ESPP program. Read SEC document |
| January 02, 2017 Filed Jan 4, 2017 12:11 UTC | INPHI Corp IPHI · Entity 140160 | Tax withholdingCommon Stock | 5,795 | $44.62 | $258,572.90 |
DisclosureSEC source: 0001437749-17-000097 · rdgdoc.xml · nonDerivative · entry 1 Ogawa Richard · CIK 0001568078 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,141 F1 · balance_after: Includes 463 shares acquired through the Company's qualified ESPP program on 08/09/2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.